Efsubaglutide Alfa
Evaluating Anti-Obesity Medications 6 Months After Metabolic Surgery
Shanghai Yinnuo Pharmaceutical Technology Co · Phase 4 · Recruiting · Enrollment 60
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Efsubaglutide Alfa group | Obesity or overweight | n/r | 3 | n/r | n/r |
| control group | Obesity or overweight | n/r | 3 | n/r | n/r |